Update: 03.05.2025
Last week: 21 week 2025 (19.05.2025 - 25.05.2025)
Last full month: April 2025
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | |||||||||
| WoW | 9 638 | -3.1% | 13.6% | 0.6 | 22 146 628 | -3.1% | 10.3% | 0.4 | -7.7% |
| MoM | 41 693 | -9.4% | 12.6% | -0.2 | 93 772 540 | -6.5% | 9.5% | -0.1 | -7.7% |
| YTD | 192 925 | 26.8% | 12.8% | 1.7 | 421 750 283 | 24.4% | 9.5% | 0.1 | 9.9% |
| MAT | 462 248 | 25.7% | 13.0% | 2.9 | 921 858 809 | 19.9% | 9.4% | 0.8 | -2.6% |
| BRAINMAX | |||||||||
| WoW | 2 378 | -12.4% | 100.0% | 0 | 7 979 924 | -15.7% | 100.0% | 0 | -12.4% |
| MoM | 11 719 | -12.4% | 100.0% | 0 | 41 169 227 | -8.3% | 100.0% | 0 | -12.4% |
| YTD | 52 284 | 128.7% | 100.0% | 0 | 180 952 380 | 124.3% | 100.0% | 0 | 128.7% |
| MAT | 112 087 | 106.0% | 100.0% | 0 | 387 004 130 | 102.9% | 100.0% | 0 | 106.0% |
| GOLDLINE PLUS | |||||||||
| WoW | 16 685 | -7.7% | 45.7% | -0.1 | 53 105 707 | -8.3% | 36.7% | -0.4 | -7.5% |
| MoM | 72 821 | -6.8% | 45.4% | -1.7 | 233 845 743 | -7.7% | 37.3% | -1.3 | -3.3% |
| YTD | 345 083 | -4.3% | 45.8% | 1.3 | 1 112 604 276 | -2.7% | 37.4% | 1.1 | -6.9% |
| MAT | 813 773 | -5.7% | 46.0% | 0.6 | 2 571 996 050 | -5.6% | 37.7% | -0.7 | -6.9% |
| MIGRENIUM | |||||||||
| WoW | 7 812 | -11.0% | 0.4% | 0 | 2 765 120 | -10.8% | 0.5% | 0 | -7.0% |
| MoM | 34 261 | -11.6% | 0.3% | 0 | 12 120 830 | -11.3% | 0.5% | 0 | -7.6% |
| YTD | 172 141 | -33.0% | 0.4% | -0.2 | 60 396 057 | -21.2% | 0.5% | -0.2 | 5.6% |
| MAT | 483 150 | -25.0% | 0.4% | -0.1 | 165 376 295 | 7.7% | 0.6% | 0 | 0.6% |
| MODELAX-N | |||||||||
| WoW | 24 200 | -5.1% | 17.7% | 0.2 | 13 665 560 | -4.7% | 13.4% | 0.2 | -6.1% |
| MoM | 114 169 | -9.4% | 18.7% | -0.5 | 61 079 234 | -7.6% | 13.7% | 0 | -7.2% |
| YTD | 605 843 | -6.4% | 20.0% | -3.4 | 319 337 627 | 17.7% | 14.4% | -0.5 | 9.6% |
| MAT | 1 421 968 | 3.3% | 20.3% | -0.4 | 707 373 552 | 37.0% | 14.0% | 1.7 | 5.6% |
| REDUXIN | |||||||||
| WoW | 10 984 | -9.6% | 30.1% | -0.7 | 61 110 610 | -9.4% | 42.2% | -1 | -7.5% |
| MoM | 50 473 | -3.6% | 31.5% | -0.1 | 272 682 487 | -4.4% | 43.5% | 0 | -3.3% |
| YTD | 238 008 | -11.4% | 31.6% | -1.6 | 1 297 262 521 | -11.0% | 43.6% | -2.6 | -6.9% |
| MAT | 564 851 | -8.5% | 31.9% | -0.6 | 3 003 702 241 | -4.1% | 44.0% | -0.1 | -6.9% |
| REDUXIN FORTE | |||||||||
| WoW | 3 986 | -3.8% | 10.9% | 0.4 | 19 359 171 | 0.5% | 13.4% | 1 | -7.5% |
| MoM | 15 756 | -0.7% | 9.8% | 0.3 | 71 449 643 | -1.6% | 11.4% | 0.3 | -3.3% |
| YTD | 75 433 | 7.3% | 10.0% | 1.3 | 343 738 579 | 12.2% | 11.6% | 1.8 | -6.9% |
| MAT | 172 520 | 2.0% | 9.8% | 0.8 | 758 984 917 | 7.0% | 11.1% | 1.1 | -6.9% |
| SALVISAR | |||||||||
| WoW | 11 534 | -9.3% | 1.5% | 0 | 5 930 659 | -9.4% | 1.5% | 0 | -7.8% |
| MoM | 54 824 | -3.3% | 1.7% | 0 | 27 866 396 | -1.2% | 1.7% | 0 | -2.2% |
| YTD | 275 658 | 22.6% | 1.8% | 0.4 | 135 865 184 | 53.2% | 1.7% | 0.5 | -3.9% |
| MAT | 622 655 | 24.3% | 1.6% | 0.4 | 288 126 783 | 59.3% | 1.5% | 0.5 | -6.8% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 192 925 | 26.8% | 12.8% | 1.7 | 421 750 283 | 24.4% | 9.5% | 0.1 | 9.9% |
| BRAINMAX | 52 284 | 128.7% | 100.0% | 0 | 180 952 380 | 124.3% | 100.0% | 0 | 128.7% |
| GOLDLINE PLUS | 345 083 | -4.3% | 45.8% | 1.3 | 1 112 604 276 | -2.7% | 37.4% | 1.1 | -6.9% |
| MIGRENIUM | 172 141 | -33.0% | 0.4% | -0.2 | 60 396 057 | -21.2% | 0.5% | -0.2 | 5.6% |
| MODELAX-N | 605 843 | -6.4% | 20.0% | -3.4 | 319 337 627 | 17.7% | 14.4% | -0.5 | 9.6% |
| REDUXIN CAPS | 238 008 | -11.4% | 31.6% | -1.6 | 1 297 262 521 | -11.0% | 43.6% | -2.6 | -6.9% |
| REDUXIN FORTE | 75 433 | 7.3% | 10.0% | 1.3 | 343 738 579 | 12.2% | 11.6% | 1.8 | -6.9% |
| SALVISAR | 275 658 | 22.6% | 1.8% | 0.4 | 135 865 184 | 53.2% | 1.7% | 0.5 | -3.9% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 462 248 | 25.7% | 13.0% | 2.9 | 921 858 809 | 19.9% | 9.4% | 0.8 | -2.6% |
| BRAINMAX | 112 087 | 106.0% | 100.0% | 0 | 387 004 130 | 102.9% | 100.0% | 0 | 106.0% |
| GOLDLINE PLUS | 813 773 | -5.7% | 46.0% | 0.6 | 2 571 996 050 | -5.6% | 37.7% | -0.7 | -6.9% |
| MIGRENIUM | 483 150 | -25.0% | 0.4% | -0.1 | 165 376 295 | 7.7% | 0.6% | 0 | 0.6% |
| MODELAX-N | 1 421 968 | 3.3% | 20.3% | -0.4 | 707 373 552 | 37.0% | 14.0% | 1.7 | 5.6% |
| REDUXIN CAPS | 564 851 | -8.5% | 31.9% | -0.6 | 3 003 702 241 | -4.1% | 44.0% | -0.1 | -6.9% |
| REDUXIN FORTE | 172 520 | 2.0% | 9.8% | 0.8 | 758 984 917 | 7.0% | 11.1% | 1.1 | -6.9% |
| SALVISAR | 622 655 | 24.3% | 1.6% | 0.4 | 288 126 783 | 59.3% | 1.5% | 0.5 | -6.8% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 9 638 | -3.1% | 13.6% | 0.6 | 22 146 628 | -3.1% | 10.3% | 0.4 | -7.7% |
| BRAINMAX | 2 378 | -12.4% | 100.0% | 0 | 7 979 924 | -15.7% | 100.0% | 0 | -12.4% |
| GOLDLINE PLUS | 16 685 | -7.7% | 45.7% | -0.1 | 53 105 707 | -8.3% | 36.7% | -0.4 | -7.5% |
| MIGRENIUM | 7 812 | -11.0% | 0.4% | 0 | 2 765 120 | -10.8% | 0.5% | 0 | -7.0% |
| MODELAX-N | 24 200 | -5.1% | 17.7% | 0.2 | 13 665 560 | -4.7% | 13.4% | 0.2 | -6.1% |
| REDUXIN CAPS | 10 984 | -9.6% | 30.1% | -0.7 | 61 110 610 | -9.4% | 42.2% | -1 | -7.5% |
| REDUXIN FORTE | 3 986 | -3.8% | 10.9% | 0.4 | 19 359 171 | 0.5% | 13.4% | 1 | -7.5% |
| SALVISAR | 11 534 | -9.3% | 1.5% | 0 | 5 930 659 | -9.4% | 1.5% | 0 | -7.8% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 41 693 | -9.4% | 12.6% | -0.2 | 93 772 540 | -6.5% | 9.5% | -0.1 | -7.7% |
| BRAINMAX | 11 719 | -12.4% | 100.0% | 0 | 41 169 227 | -8.3% | 100.0% | 0 | -12.4% |
| GOLDLINE PLUS | 72 821 | -6.8% | 45.4% | -1.7 | 233 845 743 | -7.7% | 37.3% | -1.3 | -3.3% |
| MIGRENIUM | 34 261 | -11.6% | 0.3% | 0 | 12 120 830 | -11.3% | 0.5% | 0 | -7.6% |
| MODELAX-N | 114 169 | -9.4% | 18.7% | -0.5 | 61 079 234 | -7.6% | 13.7% | 0 | -7.2% |
| REDUXIN CAPS | 50 473 | -3.6% | 31.5% | -0.1 | 272 682 487 | -4.4% | 43.5% | 0 | -3.3% |
| REDUXIN FORTE | 15 756 | -0.7% | 9.8% | 0.3 | 71 449 643 | -1.6% | 11.4% | 0.3 | -3.3% |
| SALVISAR | 54 824 | -3.3% | 1.7% | 0 | 27 866 396 | -1.2% | 1.7% | 0 | -2.2% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе “MS of competitors” в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection “MS of competitors” in sections for each brand
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #90"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #10"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #30"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #60"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #90"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #20"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #20"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе “MS of competitors” в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection “MS of competitors” in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs